Advances in Clinical Chemistry
- 1st Edition, Volume 107 - March 10, 2022
- Latest edition
- Editor: Gregory S. Makowski
- Language: English
Advances in Clinical Chemistry, Volume 107, the latest installment in this internationally acclaimed series, contains chapters authored by world-renowned clinical laboratory scient… Read more
Advances in Clinical Chemistry, Volume 107, the latest installment in this internationally acclaimed series, contains chapters authored by world-renowned clinical laboratory scientists, physicians and research scientists. The serial discusses the latest and most up-to-date technologies related to the field of clinical chemistry, with this new release focusing on Advances in Quantum Dots as Diagnostic Tools, Host polymorphisms and COVID-19 infection, Biomarkers in Muscle Invasive Bladder Cancer, and more.
- Provides the most up-to-date technologies in clinical chemistry and clinical laboratory science
- Authored by world renowned clinical laboratory scientists, physicians and research scientists
- Presents the international benchmark for novel analytical approaches in the clinical laboratory
Clinical Laboratory Professionals, Physicians and Research Scientists
1. Advances in quantum dots as diagnostic tools
Ana Soldado, Laura Cid Barrio, María Díaz-Gonzalez, Alfredo de la Escosura-Muñiz, and Jose Manuel Costa-Fernandez
2. Host polymorphisms and COVID-19 infection
Joris R. Delanghe and Marijn M. Speeckaert
3. Clinical metabolomics for inborn errors of metabolism
Lisa Ford, Matthew Mitchell, Jacob Wulff, Annie Evans, Adam Kennedy, Sarah Elsea, Bryan Wittmann, and Douglas Toal
4. Amino acids in inflammatory bowel diseases: Modern diagnostic tools and methodologies
Juraj Piestansky, Dominika Olesova, Michaela Matuskova, Ivana Cizmarova, Petra Chalova, Jaroslav Galba, Petra Majerova, Peter Mikus, and Andrej Kovac
5. Advances in sports genomics
Ildus I. Ahmetov, Elliott C.R. Hall, Ekaterina A. Semenova, Erinija Pranckevičienė and Valentina Ginevičienė
6. Biomarkers in muscle invasive bladder cancer
Fiona Wilson, Nuradh Joseph, and Ananya Choudhury
Ana Soldado, Laura Cid Barrio, María Díaz-Gonzalez, Alfredo de la Escosura-Muñiz, and Jose Manuel Costa-Fernandez
2. Host polymorphisms and COVID-19 infection
Joris R. Delanghe and Marijn M. Speeckaert
3. Clinical metabolomics for inborn errors of metabolism
Lisa Ford, Matthew Mitchell, Jacob Wulff, Annie Evans, Adam Kennedy, Sarah Elsea, Bryan Wittmann, and Douglas Toal
4. Amino acids in inflammatory bowel diseases: Modern diagnostic tools and methodologies
Juraj Piestansky, Dominika Olesova, Michaela Matuskova, Ivana Cizmarova, Petra Chalova, Jaroslav Galba, Petra Majerova, Peter Mikus, and Andrej Kovac
5. Advances in sports genomics
Ildus I. Ahmetov, Elliott C.R. Hall, Ekaterina A. Semenova, Erinija Pranckevičienė and Valentina Ginevičienė
6. Biomarkers in muscle invasive bladder cancer
Fiona Wilson, Nuradh Joseph, and Ananya Choudhury
- Edition: 1
- Latest edition
- Volume: 107
- Published: March 10, 2022
- Language: English
GM
Gregory S. Makowski
Dr Gregory S Makowski is a board-certified clinical chemist and fellow of the National Academy of Clinical Biochemistry. Following receipt of his PhD in Biochemistry from the University of Connecticut Storrs, he pursued post-doctoral studies at the University of Connecticut School of Medicine in Farmington that culminated in joint appointments in the School of Medicine and the Department of Laboratory Medicine at John Dempsey Hospital. He has numerous clinical and basic science publications and serves on various scientific and editorial boards. He is actively engaged in the training of Pathology residents and fellows in the Department of Pathology and Laboratory Medicine at Hartford Hospital. He currently serves as Vice President Clinical Laboratory Services Hartford HealthCare in Connecticut.
Affiliations and expertise
Vice President and Chief Scientific Officer, Clinical Laboratory Partners, Newington, CT, USARead Advances in Clinical Chemistry on ScienceDirect